A Phase II Trial of Adjuvant PD-1 Blockade with Endocrine Therapy in Hormone Receptor Positive Inflammatory Breast Cancer: Circulating Biomarkers (ctDNA) & Molecular Correlates of Clinical Outcomes

11:30 am - Tuesday 19th May 2026

Speakers:

Bora Lim
Director - Translational Research
The University of Texas MD Anderson Cancer Center.